Yanan Bicon Pharmaceutical Listed Company’s Net Profit Rose 14.9% in First Half of 2022

Yanan Bicon Pharmaceutical Listed Company (延安必康制药股份有限公司) (002411.SZ) reported a net profit of 393.5 million yuan in the first half of 2022, up 14.9% year-on-year.

Meanwhile, the company posted 4 billion yuan in revenue, up 15.8% year-on-year.

At the end of the reporting period, it had 18.5 billion yuan in total assets and 10.1 billion yuan in total liabilities, with a liability-to-asset ratio of 54.3%.